Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ENOV · against 470 other Healthcare companies of similar size
Ranked #397 of 471 · scores higher than 16% of peers · safety percentile 16
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)50 peers with a safety percentile of 10–19, including ENOV · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ENOV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 444 reported | 0.93× | 0.20× | 17% | 33% | |
| BetaLower is better · 444 reported | 1.42 | 0.49 | 12% | 33% | |
| Current ratioHigher is better · 457 reported | 1.99× | 2.88× | 36% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 393 | 2.2B USD | 17 | 37 | |
| 394 | 1.18T KRW (≈$847M) | 17 | 63 | |
| 395 | 1.3B USD | 16 | 33 | |
| 396 | 7.1B CNY (≈$988M) | 16 | 46 | |
| 397 | 1.2B USD | 16 | 46 | |
| 398 | 11.1B BRL (≈$2.0B) | 16 | 60 | |
| 399 | 1.5B USD | 16 | 65 | |
| 400 | 885M USD | 15 | 33 | |
| 401 | 5.9B CNY (≈$824M) | 15 | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score